Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase

Predictive factors of relapse after dose reduction of oral 5-aminosalicylic acid in patients with ulcerative colitis in the remission phase

<h4>Objectives</h4> Useful indices to determine whether to reduce the dose of 5-aminosalicylic acid (5-ASA) in patients with ulcerative colitis (UC) during remission remain unclear. We aimed to analyze the rate and risk factors of relapse after reducing the dose of oral 5-ASA used for ma...

Full description

Bibliographic Details
Main Authors: Akira Madarame, Masakatsu Fukuzawa, Yoshiya Yamauchi, Shin Kono, Akihiko Sugimoto, Hayato Yamaguchi, Takashi Morise, Yohei Koyama, Kumiko Uchida, Maya Suguro, Taisuke Matsumoto, Kagawa Yasuyuki, Takashi Kawai, Takao Itoi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2021-01-01
Series:PLoS ONE
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336875/?tool=EBI

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8336875/?tool=EBI

Similar Items